Detalhe da pesquisa
1.
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
Lancet Oncol
; 25(5): 668-682, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552658
2.
Correction to: Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma.
Curr Oncol Rep
; 22(5): 47, 2020 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32297022
3.
Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma.
Curr Oncol Rep
; 22(2): 19, 2020 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32030483
4.
Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations.
Acta Neuropathol
; 146(6): 849-852, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37851269
5.
Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncology.
J Neurooncol
; 137(1): 155-169, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29235051
6.
Molecular characterization reveals NF1 deletions and FGFR1-activating mutations in a pediatric spinal oligodendroglioma.
Pediatr Blood Cancer
; 64(6)2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27862886
7.
Loss of CDKN1C in a Recurrent Atypical Teratoid/Rhabdoid Tumor.
J Pediatr Hematol Oncol
; 39(8): e466-e469, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28731921
8.
Survival After Relapse of Medulloblastoma.
J Pediatr Hematol Oncol
; 38(4): 269-73, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26907655
9.
Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomas.
Acta Neuropathol
; 138(5): 877-881, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515627
10.
Family Recall of and Response to Germline Pathologic Variants Found on Paired Tumor-Germline Sequencing in Pediatric Oncology.
JCO Precis Oncol
; 8: e2300539, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38484211
11.
Targeting DNA Repair and Survival Signaling in Diffuse Intrinsic Pontine Gliomas to Prevent Tumor Recurrence.
Mol Cancer Ther
; 23(1): 24-34, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37723046
12.
Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201.
Neuro Oncol
; 26(4): 735-748, 2024 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38011799
13.
Rational combination platform trial design for children and young adults with diffuse midline glioma: A report from PNOC.
Neuro Oncol
; 26(Supplement_2): S125-S135, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38124481
14.
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma.
Cancer Metab
; 12(1): 11, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38594734
15.
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma.
Neuro Oncol
; 26(Supplement_2): S155-S164, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400780
16.
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models.
Neuro Oncol
; 2024 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554031
17.
A road map for the treatment of pediatric diffuse midline glioma.
Cancer Cell
; 42(1): 1-5, 2024 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039965
18.
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium.
Cancer Discov
; 14(2): 258-273, 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37823831
19.
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma.
J Clin Invest
; 134(6)2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38319732
20.
Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas.
Acta Neuropathol
; 135(2): 299-301, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29302777